Quanterix appoints Amol Chaubal as Chief Financial Officer

Quanterix Corporation, a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it has named Amol Chaubal to the position of Chief Financial Officer (CFO), effective April 12, 2019. Amol replaces Joseph Driscoll, who is stepping down from his current role as CFO.

Our company’s accelerated growth over the past several years, combined with the magnitude of the opportunity we have to transform healthcare with digital biomarkers requires us to scale our executive team accordingly with top talent. Amol’s deep experience in diagnostics, pharmaceutical services and medical devices will be invaluable at a pivotal point in our company’s growth, fueled by regaining rights to diagnostics, new product launches, groundbreaking publications and rapid adoption of digital biomarkers in neurology and oncology research. The ability to attract talent of his caliber speaks volumes for Quanterix’ momentum and long-term potential as we propel to the next phase. I also want to thank Joe for his contributions over the last two years helping to prepare the company for a very successful IPO.”

Kevin Hrusovsky, Chief Executive Officer, President and Chairman of Quanterix

Amol brings over 20 years of experience, joining Quanterix from global medical technology company, Smith & Nephew, where he serves as CFO of Global Operations. Prior to his time at Smith & Nephew, Amol served as corporate vice president and head of finance for PARAXEL’s CRS business. He has also held various roles at Novartis, including CFO North America – Vaccines & Diagnostics as well as international roles across Switzerland, Canada and the United States. Amol has a Master of Business Administration from INSEAD and a Master of Chemical Engineering from the Indian Institute of Technology.

“I am honored to be joining an impressive leadership team that has achieved considerable success in a short time,” said Amol. “I am impassioned by Quanterix’ mission-driven work and admire Kevin’s drive to empower new advances in disease diagnosis and develop better treatments with biomarker research. I look forward to supporting the innovation and world-class performance that the company has continuously delivered.”



Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Quanterix. (2019, October 25). Quanterix appoints Amol Chaubal as Chief Financial Officer. News-Medical. Retrieved on January 28, 2022 from https://www.news-medical.net/news/20190328/Quanterix-appoints-Amol-Chaubal-as-Chief-Financial-Officer.aspx.

  • MLA

    Quanterix. "Quanterix appoints Amol Chaubal as Chief Financial Officer". News-Medical. 28 January 2022. <https://www.news-medical.net/news/20190328/Quanterix-appoints-Amol-Chaubal-as-Chief-Financial-Officer.aspx>.

  • Chicago

    Quanterix. "Quanterix appoints Amol Chaubal as Chief Financial Officer". News-Medical. https://www.news-medical.net/news/20190328/Quanterix-appoints-Amol-Chaubal-as-Chief-Financial-Officer.aspx. (accessed January 28, 2022).

  • Harvard

    Quanterix. 2019. Quanterix appoints Amol Chaubal as Chief Financial Officer. News-Medical, viewed 28 January 2022, https://www.news-medical.net/news/20190328/Quanterix-appoints-Amol-Chaubal-as-Chief-Financial-Officer.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Quanterix announces recipients of annual Accelerator Grant Program